• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CRO Revenue Growth Strong, Topping Consensus Estimates

CRO Revenue Growth Strong, Topping Consensus Estimates

March 22, 2021

CROs grew their revenue by 10.2 percent in the fourth quarter of 2020, topping consensus estimates by 4.3 percentage points, according to Baird, a financial services firm.

Meanwhile, a survey of biopharma executives found that in considering the top three potential benefits of partnering with a CRO, 75 percent of the respondents who used a CRO’s services cited faster cycles in the performance of a clinical trial, while 66 percent cited receiving scientific expertise and 62 percent cited reduced operating costs.

Of the 85 respondents who said their companies hired a CRO, 79 percent said their decision was based on the perceived quality of a CRO’s services as one of the top three reasons to choose a CRO. Sixty-four percent of respondents cited a CRO’s scientific background among the top three reasons, as did 49 percent who considered a CRO’s reputation.

Of the 143 respondents who said they were concerned about using a CRO, 43 percent cited quality, followed by capability and capacity (20 percent), IP protection (15 percent), experience (13 percent) and results control (6 percent).

The survey was conducted by Informa Pharma Intelligence and WuXi AppTec. Read the survey here: https://bit.ly/3twJ1ra.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing